MAZE

Conviction 47HealthcareScan · Fri, Jun 26, 2026

Three white soldiers

MAZE$28.45+5.29%

ResistanceSupportVol 14Insider sell

Vol MA14 1.26M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Maze Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.mazetx.com ↗

Price28.45

Change+5.29%

Gap-0.04%

Rel volume13.98×

Avg volume1.02M

Avg $ vol27.12M

SMA 2025.14

SMA 5025.73

SMA 20034.09

Price vs 50+10.57%

Price vs 200-16.54%

MA stackmixed

50/200 cross—

Supertrendup · 24.08

RSI (14)67

MACD hist0.54

MACD cross—

Stoch %K / %D79 / 82

ADX (14)21

+DI / −DI31 / 13

RSI divergence—

MACD divergence—

ATR %+5.00%

ADR %5.22%

52w high51.84

52w low11.50

From 52w high-45.11%

Above 52w low+147.39%

New 52w highNo

SqueezeOff

Bollinger width20.52%

%B1.14

Donchian pos79.06%

Donchian high29.97

Donchian low22.71

AVWAP (52w high)29.83

vs AVWAP high-4.63%

AVWAP (52w low)31.43

vs AVWAP low-9.49%

OBV trendUp

Chaikin MF (20)0.07

Today vs 20d13.98×

Avg vol (14d)1.26M

Avg vol (20d)1.02M

Avg $ vol (20d)27.12M

Market cap—

RS 3m (vs SPY)-26.64%

RS 6m (vs SPY)-42.86%

RS line new highNo

Trend template4/8

Technical rank43.2

1 week+10.79%

1 month+9.21%

3 months-10.28%

6 months-32.74%

1 year+149.34%

YTD-28.46%

P/E-11.40

P/B4.37

P/S8.92

P/FCF-13.26

EPS-3.05

Div yield—

ROE-38.37%

ROA-31.24%

Debt/Eq0.11

Current17.88

EV/EBITDA—

Gross margin—

Net margin-78.28%

Rev growth—

EPS growth-351.04%

Price target70.00

Target upside159.16%

Analyst ratingBuy

Institutional93.97%

Ent. value1.33B

Revenue20M

Net income-24.21M

Gross profit—

Free cash flow-112.73M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out55.35M

Employees141

ListedFri, Jan 31, 2025

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank43.2 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree white soldiers

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MAZE

All disclosures →

No recent disclosed trades by Congress in MAZE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MAZE · 6 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Coloma Jason V Chief Executive Officer · Common Stock · 2026-06-23	Sell	23.86K	$622K	2026-06-23	2026-06-24
Coloma Jason V Chief Executive Officer · Common Stock · 2026-06-22	Sell	1.95K	$51K	2026-06-22	2026-06-24
Coloma Jason V Chief Executive Officer · Common Stock · 2026-06-22	Sell	2.04K	$53K	2026-06-22	2026-06-24
HOMCY CHARLES J Director · Stock Option (Right to Buy) · 2026-06-08	Grant	18K	$0	2026-06-08	2026-06-10
Hoppenot Herve Director · Stock Option (Right to Buy) · 2026-06-08	Grant	18K	$0	2026-06-08	2026-06-10
SPIEGELMAN DANIEL K Director · Stock Option (Right to Buy) · 2026-06-08	Grant	18K	$0	2026-06-08	2026-06-10
Andrews Nancy C Director · Stock Option (Right to Buy) · 2026-06-08	Grant	18K	$0	2026-06-08	2026-06-10
SCHELLER RICHARD H Director · Stock Option (Right to Buy) · 2026-06-08	Grant	18K	$0	2026-06-08	2026-06-10
Lim Jonathan E Director · Stock Option (Right to Buy) · 2026-06-08	Grant	18K	$0	2026-06-08	2026-06-10
Coloma Jason V Chief Executive Officer · Common Stock · 2026-06-01	Sell	6.09K	$160K	2026-06-01	2026-06-03

SEC filings

EDGAR filings in MAZE · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.